|

Predictive Value of Early Peritraumatic Distress Screening for Childbirth-PTSD Following Unplanned Cesarean Delivery

RECRUITINGSponsored by University of British Columbia
Actively Recruiting
SponsorUniversity of British Columbia
Started2026-05-08
Est. completion2027-12
Eligibility
Age19 Years+
SexFEMALE
Healthy vol.Accepted

Summary

The goal of this observational study is to learn whether early postpartum screening tools can predict the development of childbirth-related post-traumatic stress symptoms in individuals who undergo unplanned cesarean delivery. The main questions it aims to answer are: * Do scores on the Peritraumatic Distress Inventory (PDI) collected 24-48 hours after delivery predict childbirth-related PTSD symptoms at 6 weeks postpartum? * Do scores on the City Birth Trauma Scale - Short Form (CityBiTS-SF) collected 24-48 hours after delivery predict childbirth-related PTSD symptoms at 6 weeks postpartum? Participants will: * Complete questionnaires within 24-48 hours after delivery, including the PDI, CityBiTS-SF, and Edinburgh Postnatal Depression Scale (EPDS). * Complete follow-up questionnaires at 6 weeks and 3 months postpartum, including measures of PTSD symptoms (PTSD Checklist for DSM-5, PCL-5) and depressive symptoms. Researchers will evaluate whether early screening scores are associated with later symptoms of childbirth-related PTSD and postpartum depression, and will assess the feasibility and acceptability of implementing routine inpatient screening for psychological birth trauma.

Eligibility

Age: 19 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Age ≥19 years
* Underwent unplanned cesarean delivery
* Able to provide informed consent
* Able to read and understand English questionnaires

Exclusion Criteria:

* Fetal or neonatal demise
* Unable to complete study questionnaires or provide informed consent

Conditions4

Acute Stress SymptomsDepressionPost Partum DepressionPost Traumatic Stress Disorder

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.